Results 81 to 90 of about 1,894,320 (297)

Demographic, breast-feeding, and nutritional trends among children with type 1 diabetes mellitus

Indian Journal of Endocrinology and Metabolism, 2011
Background: The pathogenesis of type 1 diabetes mellitus (T1DM) requires a genetic predisposition to particular environmental triggers that may activate mechanisms leading to progressive loss of pancreatic beta cells. Aims: We tried to compare the impact
Manash P Baruah, Ariachery C Ammini, Madan L Khurana   +2 more
doaj   +1 more source

Hypoglycemia in Type 1 Diabetes Mellitus [PDF]

Endocrinology and Metabolism Clinics of North America, 2010
Iatrogenic hypoglycemia, typically the result of the interplay of therapeutic hyperinsulinemia and compromised defenses resulting in hypoglycemia-associated autonomic failure (HAAF) in diabetes, is a problem for people with type 1 diabetes mellitus (T1DM).
openaire   +3 more sources

Enteroviruses and type 1 diabetes mellitus

Biomedicine & Pharmacotherapy, 2003
Despite decades of research, the etiology of type 1 diabetes mellitus (DM) is unknown. Several risk factors have been associated with type 1 DM, including viral infections, genetic predisposition, nutritional factors, and chemicals. Several investigators hypothesize that the etiologies of type 1 DM result from a complex interaction of genetic and ...
Harry W. Haverkos, D. Peter Drotman, Narayana Battula, Owen M. Rennert   +3 more
openaire   +3 more sources

Low-carbohydrate diets for type 1 diabetes mellitus: A systematic review

PLoS ONE, 2018
Type 1 diabetes is an autoimmune condition characterised by pancreatic beta cell destruction and absolute insulin deficiency. The strongest predictor of diabetes complications is glycaemic control and achieving HbA1c ≤ 7.0% is the primary management ...
Jessica L Turton, R. Raab, K. Rooney
semanticscholar   +1 more source

Obesity and diabetes in New Zealand [PDF]

Obesity is a risk factor for diabetes, cardiovascular disease, musculoskeletal disorders, and some cancers. Introduction It is estimated that 1.1 million adults are obese in New Zealand (that is, they have a BMI or Body Mass Index of 30 or more ...
Alexandra Marett
core  

Sevelamer, a phosphate-binding resin with beneficial effect in diabetic kidney disease; a modern paradigm shift [PDF]

, 2014
The proportion of individuals diagnosed with diabetes mellitus is increasing throughout the world, which sequentially drives upward the global frequency of diabetic kidney disease (1, 2). Diabetes is a costly and deadly disease.
Baradaran, Azar., Beladi Mousavi, Seyed seifollah., Mardani, Saeed., Shahbazian, Heshmatollah., Tamadon, Mohammad Reza.   +4 more
core  

Personalized rule-based closed-loop control algorithm for type 1 diabetes [PDF]

, 2014
Type 1 diabetes-mellitus implies a life-threatening absolute insulin deficiency. Artificial pancreas (CGM sensor, insulin pump and control algorithm) is promising to outperform current open-loop ...
García García, Fernando, García Sáez, Gema, Hernando Pérez, José Luis, Pérez Gandía, C., Rigla Cros, Mercedes, Rodríguez Herrero, Agustín   +5 more
core   +1 more source

PREVENTION AND PREDICTION IN DIABETES MELLITUS TYPE 1

Revista de la Sociedad Argentina de Diabetes, 2020
Type 1 diabetes mellitus (DM1) is a disease characterized by the autoimmune destruction of the beta cell mediated by the attack of cytotoxic T lymphocytes and in which the autoantibodies (GADA, IAA, AI2A and ZnT8A) are markers of it.
Alejandro De Dios
doaj   +1 more source

Type 1 diabetes mellitus: retrospect and prospect

Bulletin of the National Research Centre
Background Type 1 diabetes (T1D) is an autoimmune disease leading to destruction of insulin-producing pancreatic beta cells. Both genetic and environmental factors contribute to pathogenesis. The incidence of T1D is increasing worldwide, with significant
Tamer A. Addissouky, Majeed M. A. Ali, Ibrahim El Tantawy El Sayed, Yuliang Wang   +3 more
doaj   +1 more source

Fulminant type 1 diabetes mellitus with anti‐programmed cell death‐1 therapy

Journal of Diabetes Investigation, 2016
Anti‐programmed cell death‐1 (PD‐1) antibodies are regarded as a risk factor for insulin‐dependent diabetes mellitus as a side‐effect. While a small number of cases have been reported, evidence remains limited.
Masahide Okamoto, Mitsuhiro Okamoto, Koro Gotoh, T. Masaki, Yoshinori Ozeki, H. Ando, Manabu Anai, Asami Sato, Yuichi Yoshida, So Ueda, T. Kakuma, Hirotaka Shibata   +11 more
semanticscholar   +1 more source